Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
L-Leucine-1-13C
Cat. No.:
0225LY-0559
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and MS.
Size:
Add to basket
Product Overview
Description:
L-Leucine-1-13C is a 13C-labeled version of L-Leucine used to significantly boost the affinity of GLP-4.
Synonym:
L-(1-13C)Leucine; (1-13C)Leucine; 74292-94-7; Leucine 1-C-13; I36PJ2DN56; (2S)-2-amino-4-methyl(113C)pentanoic acid
CAS No.:
74292-94-7
Compound CID:
135315
Formula:
C6CH13NO2
Formula Weight:
132.17
Specification
Relative Density:
1.31 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
L-Leucine-1-13C can be used in metabolic flux analysis to study protein synthesis rates and amino acid oxidation in vivo.
Library Information
Target:
mTOR
Receptor:
mTOR
Pathways:
PI3K/Akt/mTOR signaling; Metabolism
Plate Number:
AOCL-8
Plate Location:
c3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM Water
DMSO Max Solubility:
<1 mg/mL (insoluble)
Water Max Solubility:
13.1 mg/mL; 99.11 mM
